MGTX MeiraGTx: Company Short-Term Debts

Symbol and logo of brand MeiraGTx PLC (MGTX)

The daily price chart for MeiraGTx Holdings plc (MGTX) reflects the position of an issuer currently depleting reserves due to new drug testing costs, with the indicator standing at 0.00. The business relies on environmental standards, implementing purification systems and energy efficiency within its centers. Growth prospects are based on the robotization of bioprocesses, which eliminates personnel errors and automates the creation of gene vectors.

MGTX (MeiraGTx) Short-Term Debt Volume history from 07/04/2022 to 11/01/2026

Summary analytical data breakdowns for MeiraGTx Corp (MGTX)

- current quotes and average value forecast:
Price Chart MeiraGTx|MGTX - Consensus Target
- company stock capitalization data:
Market Capitalization MeiraGTx Holdings|MGTX - Total Enterprise Value
- business book valuation details:
Book Value per Share MeiraGTx|MGTX - Book Valuation of Business|Market Value to Book Value Ratio meiragtx.com|MGTX - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital MeiraGTx Holdings plc|MGTX - Long-Term Debt to Capital|Short-Term Debt to Capital MeiraGTx Holdings plc|MGTX - Company Total Indebtedness|Debt to Book Value MeiraGTx Holdings|MGTX - Amount of Long-Term Liabilities|Company Current Liabilities MeiraGTx|Quick Liquidity Indicator meiragtx.com
- net income and valuation multiples indicators:
MGTX - Final Profit
Comprehensive company analysis:MeiraGTx - MGTX
Manufactured products of MeiraGTx Corp

In-house gene therapy vector manufacturing plants provide MeiraGTx Holdings plc (MGTX) with high operational resilience. This indicator captures the aggregate of the issuer's obligations with maturities of up to twelve months. Monitoring this metric allows an investor to recognize the threat of a cash crunch in a timely manner. Analyzing the company's current liabilities reveals the real-time pressure on liquidity. The trend of this indicator determines the transparency of the business balance sheet outside the framework of quarterly reports.

Who MeiraGTx Holdings plc competes with

TEM - Company Short-Term Debt|Qiagen NV (QGEN) - Company Current Liabilities|IONS: Company Short-Term Debts|Short-Term Debt Repligen Inc. (RGEN)|RNA (Avidity Biosciences) - Company Short-Term Debts|crisprtx.com (CRSP) - Short-Term Debt Volume|Company Short-Term Debt GeneDx (WGS)|RARE (Ultragenyx Pharmaceutical Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts BEAM (Beam Therapeutics Corp)|Company Short-Term Debts Sarepta Corp SRPT|Twist Bioscience - Company Short-Term Debts|Short-Term Indebtedness 10xgenomics.com (TXG)|NTLA (Intellia Therapeutics, Inc.) - Company Current Liabilities|STOK: Amount of Current Liabilities|Company Current Liabilities BLFS|Company Short-Term Indebtedness WVE (Wave Pharma)|Company Current Liabilities MAZE (Maze Therapeutics Inc)|SION (sionnatx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts PRME (Prime Medicine)|Company Short-Term Loans and Borrowings TSHA|QURE - Company Short-Term Debt|Short-Term Debt REGENXBIO Corp|Solid Biosciences Inc. (SLDB) - Company Short-Term Debt|OCGN (ocugen.com) - Company Short-Term Debt|PACB (PacBio) - Company Short-Term Debts|Company Short-Term Indebtedness BNTC (Benitec Biopharma Inc)|Company Short-Term Debts DSGN|Short-Term Debt Volume Rocket Corp|Company Short-Term Debt 4D Molecular Therapeutics FDMT|LXEO: Company Short-Term Indebtedness|Korro Bio, Inc - Company Short-Term Debts|Short-Term Indebtedness Editas Medicine Inc (EDIT)|Silence Therapeutics Inc. (SLN) - Company Short-Term Debt|PRQR - Short-Term Debt Volume|Company Current Liabilities CDXS|SGMO: Company Short-Term Loans and Borrowings|Company Short-Term Debt Nautilus Biotechnology (NAUT)|MGX: Current Liabilities|Company Short-Term Debt Precision BioSciences DTIL|Generation Bio Co - Company Short-Term Debt|Boundless Bio, Inc. - Company Short-Term Debts|Exicure, Inc. (XCUR) - Company Current Liabilities|imunon.com (IMNN) - Company Short-Term Debt|Company Current Liabilities Phio Pharmaceuticals Corp.|MBIO (Mustang Bio Inc) - Company Short-Term Debts|RNAZ - Short-Term Indebtedness|Company Current Liabilities BNGO (Bionano Genomics, Inc.)|Amount of Current Liabilities APDN|bluebird bio - Company Current Liabilities|IPA: Company Short-Term Indebtedness|Omega - Company Short-Term Debts|OMIC (Singular Genomics Corp) - Company Short-Term Indebtedness|Regulus Therapeutics (RGLS) - Company Short-Term Debt|Company Short-Term Indebtedness SYRS|TBIO (Telesis Bio) - Company Short-Term Debts|Company Short-Term Debts TRACON Pharmaceuticals Inc.|Company Short-Term Debt Unity Bio (UBX)